Clinical Trial

Developing a Tailored Stigma Reduction Intervention to Increase Buprenorphine Prescribing

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 29, 2025 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Buprenorphine is an evidence-based treatment for opioid use disorder that also has strong potential to reduce HIV transmission in people who use drugs. Rural health care professionals are eligible and critically needed to provide these medications, but stigma currently limits provider willingness to prescribe buprenorphine, especially in regions where mortality and HIV transmission secondary to opioid use are high. In this developmental trial, the investigators will adapt, refine, and test the feasibility of a prototype brief stigma-reduction training intervention aimed at increasing buprenorphine prescribing in the rural primary care setting.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-08-15; most recent amendment 2025-05-22.
Status change: Recruiting → Active, Not Recruiting 2025-05-22
Status change: Not Yet Recruiting → Recruiting 2023-03-02
Trial Details
NCT Number NCT05505227
Lead Sponsor Ohio University
Collaborators: Ohio State University, Rutgers University, University of North Carolina
Conditions Opioid-Related Disorders, Buprenorphine, Social Stigma, Rural Health Services
Enrollment 400 participants
Start Date 2022-09-01
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-05-29